Diatherix Laboratories FDA Grants Emergency Use Authorizations for Altona, Diatherix Eurofins Coronavirus Tests The PCR-based tests are designed to detect SARS-CoV-2 nucleic acid in various respiratory specimens including oropharyngeal and nasopharyngeal swabs. Study Shows Potential of Thermo Fisher OpenArray qPCR Platform in Multiplexed Blood Screening Premium An OpenArray panel designed to simultaneously test for 17 viruses and 13 bacteria and protozoa was able to detect pathogens from human blood donor samples with an accuracy of about 95 percent. Applied BioCode, Diatherix Ink Partnership, Supply Agreement The companies will use their respective technologies to develop multiplex molecular diagnostic panels for laboratory testing. IQuity, Diatherix Form Strategic Partnership Under the terms of the deal, IQuity's autoimmune disease diagnostics will be made available through Diatherix's CLIA-certified clinical laboratory. Diatherix, Vanderbilt University Med Center Establish Multi-Year Clinical Study Pact The provider of multiplex diagnostics services and solutions will work with VUMC to develop infectious disease assays with a particular focus on pediatric patients. Nov 17, 2015 Diatherix, Color Genomics Receive CAP Accreditation Jun 1, 2015 Eurofins Acquires Diatherix Labs Mar 11, 2015 Ubiquity Genomics Commercializing Catch-seq Target Capture Technology Premium Dec 16, 2014 FDA, HHS Awards Diatherix Contract for PCR-based Pathogen Detection Methods Aug 8, 2013 Diatherix Buys TEM-PCR from Qiagen to Expand CLIA Lab Offerings, Possibly Develop MDx Kits Premium Aug 7, 2013 Diatherix Acquires TEM-PCR Patent from Qiagen; Expands Business Model Nov 11, 2010 IRS Awards More than $9M to PCR-Related Technology as Part of Federal Grant Program Premium Mar 30, 2010 Dx Focus Mar 30, 2010: Clinical and Regulatory PCR and Nucleic Acid Testing News Premium Mar 15, 2010 Ohio Hospital Network to Use Diatherix Multiplex MDx Tests Breaking News Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design NIH Awards $73M to Continue Buildout of ClinGen The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.